- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging therapeutic targets in endometrial cancer
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 8, Issue 5, Pages 261-271
Publisher
Springer Nature
Online
2011-01-11
DOI
10.1038/nrclinonc.2010.216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) G. Plataniotis et al. ANNALS OF ONCOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
- (2010) Brian M. Slomovitz et al. CANCER
- PTEN Loss Compromises Homologous Recombination Repair in Astrocytes: Implications for Glioblastoma Therapy with Temozolomide or Poly(ADP-Ribose) Polymerase Inhibitors
- (2010) B. McEllin et al. CANCER RESEARCH
- EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma
- (2010) J. W. Lee et al. CLINICAL CANCER RESEARCH
- Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG)
- (2010) Helen J. Mackay et al. EUROPEAN JOURNAL OF CANCER
- A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies
- (2010) Sarah M. Temkin et al. GYNECOLOGIC ONCOLOGY
- Impact of Androgen-Deprivation Therapy on Physical Function and Quality of Life in Men With Nonmetastatic Prostate Cancer
- (2010) Shabbir M.H. Alibhai et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
- (2010) Martin Köbel et al. JOURNAL OF PATHOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Overexpression of EpCAM in Uterine Serous Papillary Carcinoma: Implications for EpCAM-Specific Immunotherapy With Human Monoclonal Antibody Adecatumumab (MT201)
- (2010) K. El-Sahwi et al. MOLECULAR CANCER THERAPEUTICS
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- Mismatch repair deficient colorectal cancer in the era of personalized treatment
- (2010) Madeleine Hewish et al. Nature Reviews Clinical Oncology
- PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
- (2010) K. J. Dedes et al. Science Translational Medicine
- Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting
- (2009) Elisabeth Wik et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma
- (2009) J. E. Ang et al. ANNALS OF ONCOLOGY
- The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
- (2009) K Shoji et al. BRITISH JOURNAL OF CANCER
- In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
- (2009) K El-Sahwi et al. BRITISH JOURNAL OF CANCER
- EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer
- (2009) Aparna A. Kamat et al. CANCER
- PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
- (2009) K. Kalinsky et al. CLINICAL CANCER RESEARCH
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- Systemic therapy for recurrent endometrial cancer: a review of North American trials
- (2009) Thanh H Dellinger et al. Expert Review of Anticancer Therapy
- Clinicopathologic significance of DNA mismatch repair defects in endometrial cancer: The devil is in the details
- (2009) Paul J. Goodfellow GYNECOLOGIC ONCOLOGY
- Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma
- (2009) Monica Prasad Hayes et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
- (2009) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
- (2009) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
- (2009) Felipe C Geyer et al. JOURNAL OF PATHOLOGY
- EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma
- (2009) Jeong-Won Lee et al. JNCI-Journal of the National Cancer Institute
- Concomitant PI3K–AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis
- (2009) Lluis Catasus et al. MODERN PATHOLOGY
- The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects
- (2009) D. L. Schwartz et al. MOLECULAR CANCER THERAPEUTICS
- Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941
- (2009) F. I. Raynaud et al. MOLECULAR CANCER THERAPEUTICS
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells
- (2009) Saskia M. Brachmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
- (2009) H. B. Salvesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
- (2008) G E Konecny et al. BRITISH JOURNAL OF CANCER
- HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer
- (2008) G E Konecny et al. BRITISH JOURNAL OF CANCER
- PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences
- (2008) Takahito Miyake et al. CANCER LETTERS
- Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation
- (2008) S. A. Byron et al. CANCER RESEARCH
- Aneuploidy Predicts Outcome in Patients with Endometrial Carcinoma and Is Related to Lack of CDH13 Hypermethylation
- (2008) Y. Suehiro et al. CLINICAL CANCER RESEARCH
- Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma
- (2008) L. Jia et al. CLINICAL CANCER RESEARCH
- P16 alterations increase the metastatic potential of endometrial carcinoma
- (2008) Atanas Ignatov et al. GYNECOLOGIC ONCOLOGY
- Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
- (2008) Vincent Jongen et al. GYNECOLOGIC ONCOLOGY
- Endometrioid uterine cancer: Histopathological risk factors of local and distant recurrence
- (2008) Toshio Fujimoto et al. GYNECOLOGIC ONCOLOGY
- Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148
- (2008) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Role ofKRASandEGFRAs Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
- (2008) Chang-Qi Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- ESR1amplification in endometrial carcinomas: hope or hyperbole?
- (2008) DSP Tan et al. JOURNAL OF PATHOLOGY
- Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions
- (2008) A Lebeau et al. JOURNAL OF PATHOLOGY
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Jorge S Reis-Filho et al. NATURE GENETICS
- Drug-sensitive FGFR2 mutations in endometrial carcinoma
- (2008) A. Dutt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now